We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$16.3M
(+4.5%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
27.08%
Holding
761
New
59
Increased
126
Reduced
253
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$10.6M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$7.66M |
| 3 |
iShares MSCI Malaysia ETF
EWM
|
+$6.49M |
| 4 |
UBS Group
UBS
|
+$5.93M |
| 5 |
Linde
LIN
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$10.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$10.5M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$9.79M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$8.27M |
| 5 |
Merck
MRK
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.4% |
| 2 | Technology | 12.96% |
| 3 | Financials | 11.29% |
| 4 | Healthcare | 10.46% |
| 5 | Consumer Discretionary | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
MetLife
MET
$61.4B
| $116K | 0.03% |
3,167
-959
| -23% | -$33.4K |
|
|
CGC
277
Canopy Growth
CGC
$388M
| $115K | 0.03% |
711
+606
| +577% | +$98.1K |
|
278
Newmont
NEM
$127B
| $113K | 0.03% |
1,829
+109
| +6% | +$6.45K |
|
279
CareTrust REIT
CTRE
$8.92B
| $110K | 0.03% |
+6,414
| New | +$112K |
|
280
Kiniksa Pharmaceuticals
KNSA
$6B
| $108K | 0.03% |
4,250
-1,640
| -28% | -$34.3K |
|
281
Axsome Therapeutics
AXSM
$11B
| $107K | 0.03% |
1,300
| – | – |
|
|
RSX
282
DELISTED
VanEck Russia ETF
RSX
| $106K | 0.03% |
5,113
-536,483
| -99% | -$10.6M |
|
|
XLNX
283
DELISTED
Xilinx Inc
XLNX
| $106K | 0.03% |
1,076
-120
| -10% | -$10.6K |
|
284
Consolidated Edison
ED
$38.9B
| $105K | 0.03% |
1,461
-400
| -21% | -$30.7K |
|
285
CME Group
CME
$97.8B
| $103K | 0.03% |
635
-132
| -17% | -$23.7K |
|
286
Nike
NKE
$53.1B
| $103K | 0.03% |
1,047
+6
| +0.6% | +$554 |
|
|
PPL
287
PPL Corp
PPL
$25B
| $102K | 0.03% |
3,964
-1,010
| -20% | -$26.3K |
|
288
State Street SPDR S&P Regional Banking ETF
KRE
$4.21B
| $102K | 0.03% |
2,665
| – | – |
|
289
Waste Management
WM
$85.7B
| $102K | 0.03% |
963
-275
| -22% | -$27.8K |
|
290
Sarepta Therapeutics
SRPT
$2.09B
| $102K | 0.03% |
636
| – | – |
|
291
Omega Healthcare
OHI
$14.2B
| $102K | 0.03% |
3,414
-1,448
| -30% | -$42.9K |
|
292
Procure Space ETF
UFO
$544M
| $101K | 0.03% |
+5,000
| New | +$94.6K |
|
293
Vanguard Energy ETF
VDE
$10.8B
| $101K | 0.03% |
2,000
| – | – |
|
294
Merit Medical Systems
MMSI
$5.15B
| $100K | 0.03% |
2,196
-308
| -12% | -$12.4K |
|
295
Regenxbio
RGNX
$521M
| $100K | 0.03% |
2,714
+2,700
| +19,286% | +$101K |
|
|
MASI
296
DELISTED
Masimo
MASI
| $98K | 0.03% |
430
-97
| -18% | -$21.3K |
|
297
Zymeworks
ZYME
$1.86B
| $97.4K | 0.03% |
+2,700
| New | +$99.4K |
|
298
Rapid7
RPD
$834M
| $96.3K | 0.03% |
1,887
-3,626
| -66% | -$169K |
|
299
HCA Healthcare
HCA
$93.2B
| $96.2K | 0.03% |
991
-3,494
| -78% | -$363K |
|
300
Service Corp International
SCI
$10.9B
| $95.7K | 0.03% |
+2,462
| New | +$94.6K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2020 Portfolio in Review
As of Q2 2020, Exane Derivatives held 761 positions worth $374M, up 4.5% from $358M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $27.4M in Q2 2020, closing 72 positions and reducing 253 holdings. Its most notable exit was iShares MSCI Turkey ETF, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Exane Derivatives opened a new position in iShares MSCI South Africa ETF worth $8.2M.
- Exane Derivatives's largest Q2 2020 buy was iShares MSCI South Africa ETF: 232,582 shares worth $8.2M.
- Exane Derivatives added most to iShares MSCI China ETF in Q2 2020, an estimated $10.6M increase.
- Exane Derivatives's biggest Q2 2020 reduction was VanEck Russia ETF, cutting an estimated $10.6M.
- Exane Derivatives fully exited iShares MSCI Turkey ETF in Q2 2020, selling an estimated $10.5M.
- Exane Derivatives's ten largest holdings make up 27% of its $374M portfolio in Q2 2020.
- Exane Derivatives opened 59 new positions and closed 72 in Q2 2020.
- Exane Derivatives's portfolio value rose 4.5% quarter-over-quarter to $374M.
Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.